ENTERPRISE CLINICAL RESOURCE

Complete FDA-Approved Testosterone Replacement Therapy Guide

The most comprehensive clinical resource for testosterone replacement therapy in the United States. Evidence-based protocols, all FDA-approved formulations, and expert clinical guidance.

1,200+ Patients Treated
🏥
100% FDA Compliance
📊
95% Patient Satisfaction
🔬
24/7 Clinical Support

Injectable Testosterone Formulations

FDA-approved injectable formulations offer the most reliable and cost-effective treatment options

💉

Testosterone Enanthate FDA Approved

Nearly identical to cypionate with slightly shorter half-life. Preferred in European protocols.

📊 Clinical Data

  • Half-life: 4.5-7 days
  • Peak levels: 36-48 hours
  • Duration: 7-10 days
  • Bioavailability: 100% (intramuscular)

Available Forms

  • Generic: 200mg/mL vials
  • Delatestryl®: Brand name by Endo Pharmaceuticals
  • Xyosted®: Auto-injector (50mg, 75mg, 100mg weekly)
  • Cost: $45-110/month (generic), $500+ (Xyosted)
💉

Testosterone Undecanoate (Aveed®) FDA Approved REMS Program

Ultra-long-acting formulation requiring only 5 injections per year after loading phase.

⚠️ REMS Requirements

Due to risk of pulmonary oil microembolism (POME), must be administered in certified healthcare settings with 30-minute observation period.

Dosing Protocol

  • Loading: 750mg at weeks 0, 4
  • Maintenance: 750mg every 10 weeks
  • Injection volume: 3mL deep IM
  • Cost: $1,200-1,500 per injection
🔧

Xyosted® Auto-Injector FDA Approved Subcutaneous

First FDA-approved subcutaneous testosterone auto-injector for weekly self-administration.

Key Features

  • Pre-filled single-use auto-injectors
  • Subcutaneous administration (not IM)
  • Available: 50mg, 75mg, 100mg
  • No dose adjustments needed
  • Cost: $500-700/month

Clinical Injection Guidelines

Recommended Sites

  • Ventrogluteal (preferred)
  • Vastus lateralis
  • Deltoid (≤1mL only)
  • Dorsogluteal (avoid if possible)

Needle Selection

  • Gauge: 23-25G
  • Length: 1-1.5" (IM)
  • Length: 0.5" (SubQ)
  • 3mL luer-lock syringe

Storage Requirements

  • Room temp: 68-77°F
  • Protect from light
  • Do not refrigerate
  • 28-day stability after puncture

Topical Testosterone Formulations

FDA-approved gels and solutions provide daily application convenience with steady hormone levels

⚠️ Transfer Risk Warning

All topical formulations carry risk of transfer to women, children, and pets. Strict precautions required including hand washing, covering application sites, and avoiding skin contact.

🧴

AndroGel® FDA Approved Market Leader

Most prescribed topical testosterone with two concentration options.

Formulations

Concentration Starting Dose Application Sites Bioavailability
1% gel 50mg (5g gel) Shoulders, upper arms 9-14%
1.62% gel 40.5mg (2 pumps) Shoulders, upper arms only 10-12%
  • Apply same time daily after showering
  • Wash hands immediately after application
  • Cost: $400-600/month (generic: $200-300)
🧴

Testim® FDA Approved

1% gel with pentadecalactone permeation enhancer for improved absorption.

Key Features

  • 30% higher peak levels vs AndroGel 1%
  • Starting dose: 50mg (5g tube)
  • Distinctive odor from enhancer
  • Slightly sticky texture
  • Cost: $500-700/month
🧴

Fortesta® FDA Approved Thigh Application

2% gel allowing smaller application volume and unique thigh application site.

Unique Features

  • Only gel approved for thigh application
  • Starting dose: 40mg (4 pump actuations)
  • Dose titration based on 2-hour levels
  • Metered-dose pump bottle
  • Cost: $600-800/month
🧴

Vogelxo® FDA Approved

1% gel available in tubes, packets, and pump.

Delivery Options

  • Tubes: 50mg, 100mg doses
  • Packets: 50mg, 100mg doses
  • Pump: 12.5mg per actuation
  • Application: shoulders/upper arms
  • Cost: $400-600/month
💧

Axiron® FDA Approved Underarm Application

2% topical solution with unique underarm application using applicator.

Application Protocol

  • Starting dose: 60mg (30mg per axilla)
  • Apply using provided applicator
  • Compatible with deodorant use
  • No-touch applicator reduces transfer risk

Clinical Advantages

  • Reduced transfer risk vs other sites
  • Quick drying (3-5 minutes)
  • Alcohol-based solution
  • Cost: $500-700/month

Transdermal Testosterone Patches

FDA-approved patch system providing continuous hormone delivery

🩹

Androderm® FDA Approved

The only FDA-approved testosterone patch system in the United States.

📊 Clinical Data

  • Steady-state levels achieved in 7-10 days
  • Mimics circadian rhythm when applied nightly
  • Bioavailability: ~10% of applied dose
  • No first-pass metabolism

Available Strengths & Dosing

Strength Testosterone Delivered Application Typical Use
2mg/day patch ~2mg over 24 hours One patch nightly Starting dose
4mg/day patch ~4mg over 24 hours One patch nightly Standard dose
6mg/day (2 patches) ~6mg over 24 hours Two patches nightly High dose

Application Sites

  • Back, abdomen, thighs, upper arms
  • Avoid bony prominences and oily skin
  • Rotate sites to prevent irritation
  • Do not apply to scrotum

⚠️ Common Side Effects

Skin irritation occurs in up to 37% of patients. Pre-treatment with topical corticosteroids may help. Discontinuation due to skin reactions: ~10%.

Cost & Considerations

  • Cost: $600-800/month
  • Must be worn continuously
  • May fall off during exercise/sweating
  • MRI-safe but should be removed

Oral Testosterone Formulations

Modern FDA-approved oral options eliminate historical hepatotoxicity concerns

💊

Jatenzo® FDA Approved 2019

Testosterone undecanoate soft gelatin capsules with lymphatic absorption.

Dosing Protocol

  • Starting: 237mg twice daily
  • Range: 158-396mg twice daily
  • Must take with food (fat required)
  • Titrate based on 6-hour post-dose levels

✓ Safety Profile

No liver enzyme elevation in 2-year studies. Safe alternative to methylated oral steroids.

Cost: $900-1,500/month

💊

TLANDO® FDA Approved 2022

Fixed-dose testosterone undecanoate with simplified monitoring.

Key Features

  • Fixed dose: 225mg twice daily
  • No dose titration in 80% of patients
  • Take with meals
  • Check levels at 3-4 weeks only

Cost: $900-1,400/month

⚠️

Methyltestosterone Not Recommended

17α-alkylated oral testosterone with significant hepatotoxicity.

⚠️ Black Box Warning

Associated with cholestatic jaundice, peliosis hepatis, liver tumors, and hepatocellular carcinoma. AUA guidelines recommend against use.

Still FDA-approved but contraindicated for TRT

Alternative Delivery Systems

FDA-approved specialized delivery methods for specific patient needs

Testopel® Pellets FDA Approved

Subcutaneous pellet implants providing 3-6 months of therapy.

Procedure Details

  • 8-12 pellets (75mg each)
  • Local anesthesia required
  • 5mm incision in upper buttock
  • 10-15 minute procedure

Considerations

  • Infection rate: 0.3-6.8%
  • Extrusion rate: up to 12%
  • Cannot adjust dose between procedures
  • Cost: $650-2,000 per procedure
👃

Natesto® FDA Approved Nasal Gel

Intranasal testosterone gel with TID dosing.

Unique Features

  • Dose: 11mg per nostril TID
  • No transfer risk to others
  • Maintains LH/FSH production
  • May preserve fertility

Side Effects

  • Nasal irritation: 10-20%
  • Rhinorrhea, epistaxis possible
  • Cost: $700-900/month
🦷

Striant® FDA Approved Buccal

Buccal adhesive testosterone system applied to gums.

Application

  • 30mg tablet applied BID
  • Adheres to gum above incisor
  • 12-hour controlled release
  • No first-pass metabolism

Considerations

  • Gum irritation common
  • Altered taste possible
  • Must avoid dislodging
  • Cost: $600-800/month

Comprehensive Formulation Comparison

Evidence-based selection criteria for optimal patient outcomes

Formulation Frequency Peak Time Steady State Monthly Cost Transfer Risk Key Advantages
Cypionate IM Weekly 24-48h 4-5 weeks $40-105 None Gold standard, cost-effective
Enanthate IM Weekly 36-48h 4-5 weeks $45-110 None Similar to cypionate
Xyosted SC Weekly 36h 6 weeks $500-700 None Auto-injector convenience
Aveed IM 10 weeks 7 days 3rd dose $400-500 None Infrequent dosing
AndroGel Daily 2-4h 3-5 days $200-600 High No injections
Axiron Daily 2-8h 14 days $500-700 Moderate Underarm application
Androderm Daily 8-24h 7-10 days $600-800 Low Circadian mimicry
Jatenzo Twice daily 5h 7 days $900-1500 None Oral convenience
Testopel 3-6 months 1 month Immediate $200-500 None Long duration
Natesto Three daily 60 min 3-5 days $700-900 None Preserves fertility

Evidence-Based Clinical Benefits

Comprehensive outcomes data from landmark clinical trials

Sexual Function Improvements

📊 Testosterone Trials (2016)

790 men aged ≥65 years with testosterone <275 ng/dL

  • Sexual activity increased by 0.58 activities/week (p<0.001)
  • Sexual desire improved in 64% vs 31% placebo
  • Erectile function improved (IIEF +2.64 points)
  • Effects seen within 3-6 weeks
  • Greater benefit with baseline T <200 ng/dL

Metabolic Health Benefits

  • HbA1c reduction: -0.7% in diabetic men
  • Insulin sensitivity: +25% (HOMA-IR)
  • Total cholesterol: -12 mg/dL
  • LDL cholesterol: -14 mg/dL
  • Inflammatory markers: CRP -0.54 mg/L

Body Composition Changes

  • Lean mass: +1.9 kg average increase
  • Fat mass: -1.2 kg average decrease
  • Trunk fat: -0.9 kg reduction
  • Muscle strength: +10-13% improvement
  • Effects maximized with resistance training

Bone Density Improvements

⚠️ TRAVERSE Fracture Substudy

Despite BMD improvements, fracture rates were higher with TRT (3.5% vs 2.5%). Clinical significance unclear.

  • Lumbar spine BMD: +3-8% at 12 months
  • Femoral neck BMD: +1-3% at 12 months
  • Bone formation markers increased
  • Greater effect with lower baseline T

Cognitive Function

  • Spatial memory: Modest improvements
  • Verbal memory: No significant change
  • Executive function: Mixed results
  • Depression scores: -2.5 points (BDI)
  • Quality of life: Improved in most studies

Cardiovascular Safety - TRAVERSE Study

✓ 2023 FDA Label Update

Cardiovascular warnings removed following TRAVERSE results showing no increased MACE risk.

  • 5,246 men with CVD or high risk
  • MACE rate: 7.0% TRT vs 7.3% placebo
  • No difference in MI, stroke, or CV death
  • Small BP increase: +2.4 mmHg systolic
  • AFib slightly increased: 3.5% vs 2.4%

Clinical Monitoring Protocols

Evidence-based monitoring ensures safety and efficacy

Baseline Assessment

Required Labs

  • Total testosterone (2 morning samples)
  • Free testosterone (calculated or equilibrium dialysis)
  • LH, FSH (distinguish primary vs secondary)
  • Complete blood count
  • Comprehensive metabolic panel
  • Lipid panel
  • PSA (men >40 or high risk)

Clinical Assessment

  • Digital rectal exam (if indicated)
  • Blood pressure measurement
  • Calculate BMI
  • Assess cardiovascular risk
  • Screen for sleep apnea
  • Fertility desires
  • Medication review

Laboratory Monitoring

  • Testosterone level (trough for injections)
  • Hematocrit (target <54%)
  • PSA if baseline obtained
  • Symptom assessment
  • Blood pressure check

Dose Adjustments

  • Target T level: 400-600 ng/dL (trough)
  • Adjust by 25-50mg increments
  • Consider peak levels if symptoms persist
  • Testosterone and free testosterone
  • CBC with hematocrit
  • Comprehensive metabolic panel
  • Lipid panel
  • PSA (controversial if stable)
  • DRE if indicated
  • Bone density (if osteoporosis risk)
  • Cardiovascular risk reassessment

Real Patient Transformations

"After struggling with fatigue and low libido for years, testosterone cypionate changed my life. I feel like I'm in my 30s again at 52. The weekly injections are easy, and the results have been incredible."

MT
Michael T.

Salt Lake City, UT • Cypionate Patient

"As a veteran, I appreciate Arsenal's military-friendly approach. The Xyosted auto-injector works perfectly with my active lifestyle. No more mixing vials or worrying about technique."

JR
James R.

Ogden, UT • Xyosted Patient

"I travel constantly for work, so the oral Jatenzo has been perfect. No needles, no gels to worry about transferring. Just take with meals and go. Worth every penny."

RK
Robert K.

Park City, UT • Jatenzo Patient

📋 Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice. All treatment decisions must be made by licensed medical providers based on individual patient assessment. FDA approval status current as of 2024. Individual results may vary. Testosterone replacement therapy requires a prescription from a licensed provider.